Please try another search
Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. The company was incorporated in 1994 and is headquartered in Toyonaka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Kentaro Ishigami | 50 | 2015 | President & Chairman |
Osami Kajimoto | 61 | 2002 | Part-Time Director |
Tomoaki Sugino | 55 | 2010 | Director |
Masakazu Nakajima | 49 | 2020 | Independent Outside Director |
Hiroyuki Yamamoto | 71 | 2023 | Independent Outside Director |
Kazuhiro Hayashi | 72 | 2008 | Full-Time Auditor |
Naoji Ichida | 39 | 2020 | Auditor |
Xu Deng | 46 | 2023 | Independent Outside Director |
Reiri Furutani | 55 | 2020 | Auditor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review